자주 묻는 질문

What is Gemtuzumab Ozogamicin used for?

An antibody-drug conjugate consisting of a monoclonal antibody targeting CD33 on leukemia cells, linked to a potent cytotoxic agent that causes DNA strand breaks when internalized. It is used to treat acute myeloid leukemia in adults and children by selectively delivering chemotherapy directly to cancer cells. This targeted approach aims to minimize damage to healthy tissue compared to conventional chemotherapy.

Is Gemtuzumab Ozogamicin an approved drug?

Yes, Gemtuzumab Ozogamicin is an approved drug. It has reached clinical phase 4. It is classified as a Antibody drug conjugate.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

• ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201506. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.